Sterile Compounding Pharmacies Market Size & Growth 2021, 28

    Sterile Compounding Pharmacies Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Injectable Drugs and Infusions) and Route of Administration (Intravenous, Intramuscular, and Subcutaneous), and Geography

    Publication Month: Dec 2021 | Report Code: TIPRE00026302 | No. of Pages: 163 | Category: Pharmaceuticals | Status: Published

    The sterile compounding pharmacies market is projected to reach US$ 6,198.59 million by 2028 from US$ 3,968.70 million in 2021; it is expected to grow at a CAGR of 6.6% from 2021 to 2028.

    Factors such as the rise in the uptake of personalized medicines and the benefits associated with on-site sterile compounding drive the growth of the market. However, product recalls and stringent regulatory requirements impede market growth. On the other hand, the development of centralized or regional compounding centers for customized formulations would create lucrative opportunities for market growth during the forecast period.

    North America is likely to continue its dominance in the sterile compounding pharmacies market during 2021–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period. This is primarily attributed to the rising pharmaceutical spending and the well-established healthcare infrastructure. For example, the Food and Drug Administration (FDA) has designated 503B (For records, 503B is referred to as an outsourcing facility and is sometimes referred to as 503B pharmacies and are strictly monitored by the FDA that establishes a new level of patient care and safety). Also, almost 75% of hospitals in the US outsource sterile compounding preparations to 503B facilities to ensure stability, cope up with drug shortages, obtain a ready-to-administer form of the drug, and extend shelf-life. Furthermore, the rising geriatric population and growing adoption of customized formulations over commercial products are expected to drive the growth of the US sterile compounding pharmacies market in the coming years.


    Strategic Insights

    Lucrative Regions for Sterile Compounding Pharmacies Market

    Lucrative Regions for Sterile Compounding Pharmacies Market

    Get more information on this report :

    Market Insights

    Benefits of On-Site Sterile Compounding Drive Market Growth

    On-site compounding and sterilization can prove vital in case of an intravenous solution intended to be customized as per the patient's need. On-site manufacturing allows the active pharmaceutical ingredient (API) to be introduced to human subjects during the starting phases of early clinical drug development. Sterile extemporaneous compounding offers a flexible option to the costly, extended development of parenteral investigational products designed by the Good Manufacturing (GMP) standards. Typically, parenterally administered API for clinical studies are manufactured under GMP conditions. This potentially reduces the time required for producing a finished product needed for specific dosing.

    Moreover, compounding and filtering a formulation into a sterile intravenous solution successfully is met through strong collaboration with the pharmaceutical sponsor and clinical site pharmacists, where sterility testing can be conducted efficiently.

    On-site sterile compounding has gained significant attention in the global market and is one of the most impacting factors responsible for market growth. This is due to sterile compounding pharmacists are focusing more on the latest research activities, innovative techniques, quality control rules, and getting the best ingredients to meet patients' needs. For example, the National Association of Boards of Pharmacy (NABP) announced receiving funding from the Food and Drug Administration (FDA) to develop a data-sharing system to improve oversight of sterile compounding pharmacies. This new system is expected to assist in collecting, managing, and sharing information related to sterile compounding in the US. The project also aims to reduce the risk of injury, favoring patients from drug products that have been improperly compounded.

    Product-Based Insights

    Based on product, the sterile compounding pharmacies market is bifurcated into injectable drugs and infusions. The injectable drugs segment would account for a larger market share during 2021–2028. Injectable drugs are among the highly preferred sterile compounding products due to their faster mode of action. To avoid any adverse effects on the patients, compounded injectable drugs (defined as drugs that are diluted, mixed, reconstituted, and prepared in an office) are compounded in such an environment where appropriate safeguards are maintained against the spread of disease and components of compounded drugs that are the appropriate strength and makeup. Market players are adopting organic and inorganic growth strategies for market growth. For instance, in September 2019, QuVa Pharma, Inc. declared a considerable increase in capacity for compounded sterile injectable preparations.

    Sterile Compounding Pharmacies Market Size and Forecast, by Product– 2021 and 2028

    Sterile Compounding Pharmacies Market Size and Forecast, by Product– 2021 and 2028

    Get more information on this report :

    Route of Administration-Based Insights

    Based on route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous. The intravenous segment held the largest share of the market in 2020 and is projected to continue its dominance during the forecast period. However, the intramuscular segment is estimated to register the highest CAGR in the market during the forecast period. The intramuscular (IM) route of drug delivery is the most common route for parenteral injection. Many antibiotics, preoperative sedatives, and narcotics are given through the intramuscular route. For instance, in February 2021, Biogen, announced that the US Food and Drug Administration (FDA) approved a new intramuscular (IM) injection for "Plegridy (peginterferon beta-1a) responsible for treating multiple sclerosis (MS).

    Companies operating in the sterile compounding pharmacies market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

    Based on product, the sterile compounding pharmacies market is bifurcated into injectables and infusions.

    Based on route of administration, the sterile compounding pharmacies market is segmented into intravenous, intramuscular, and subcutaneous

    Sterile Compounding Pharmacies Market Size – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM


    Company Profiles

    • Fagron, Inc.
    • Triangle Compounding Pharmacy
    • B. Braun Melsungen AG
    • PharMedium Healthcare Holdings, Inc.
    • Fresenius Kabi AG
    • Avella specialty Pharmacy
    • Pencol Compounding Pharmacy
    • Pavilion Compounding Pharmacy LLC
    • Pace Pharmacy
    • SandsRx

    Frequently Asked Questions

    Sterile compounding pharmacies involve creating a medication in an environment free from viruses, bacteria, or any other potentially infectious microorganisms. Such a type of compounding is intended for medications that will be administered either through an IV or an injection.
    Rising uptake of personalized medicines and the benefits of on-sterile compounding are the most significant factors responsible for the overall market growth.
    Based on product type, injectable drugs took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.
    The intravenous segment dominated the global sterile compounding pharmacies market and accounted for the largest revenue of 2,954.51 Mn in 2021.
    Fagron, Inc., Triangle Compounding Pharmacy, B. Braun Melsungen AG, PharMedium Healthcare Holdings, Inc., Fresenious Kabi AG, Avella Specialty Pharmacy, Pencol Compounding Pharmacy, Pavilion Compounding Pharmacy, LLC., Pace Pharmacy, and SandsRx are among the leading companies operating in the global sterile compounding pharmacies market
    Global sterile compounding pharmacies market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for sterile compounding pharmacies market. The US is estimated to hold the largest share in the sterile compounding pharmacies market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for sterile compounding pharmacies accounting fastest growth of the region during the coming years.

    Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Sterile Compounding Pharmacies Market – By Product

    1.3.2 Global Sterile Compounding Pharmacies Market – By Route of Administration

    1.3.3 Global Sterile Compounding Pharmacies Market – By Geography

    2. Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Sterile Compounding Pharmacies Market – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America PEST Analysis

    4.2.2 Europe PEST Analysis

    4.2.3 Asia Pacific PEST Analysis

    4.2.4 Middle East And Africa PEST Analysis

    4.2.5 South And Central America PEST Analysis

    4.3 Experts Opinion

    5. Sterile Compounding Pharmacies Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Rising Uptake of Personalized Medicines

    5.1.2 Benefits of On-site Sterile Compounding

    5.2 Market Restraints

    5.2.1 Product Recalls and Stringent Regulatory Requirements

    5.3 Market Opportunities

    5.3.1 Development of Centralized or Regional Compounding Centers for Customized Formulation

    5.4 Future Trends

    5.4.1 Continued Support for Outsourcing Facilities and Manufacturing

    5.5 Impact Analysis

    6. Sterile Compounding Pharmacies Market– Global Analysis

    6.1 Global Sterile Compounding Pharmacies Market Revenue Forecast and Analysis

    6.2 Global Sterile Compounding Pharmacies Market, By Geography - Forecast and Analysis

    6.3 Market Positioning of Key Players

    7. Global Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028– by Product

    7.1 Overview

    7.2 Global Sterile Compounding Pharmacies Market, By Product, 2021 & 2028 (%)

    7.3 Injectable Drugs

    7.3.1 Overview

    7.3.2 Injectable Drugs: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    7.4 Infusions

    7.4.1 Overview

    7.4.2 Infusions: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    8. Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 – Route of Administration

    8.1 Overview

    8.2 Global Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)

    8.3 Subcutaneous

    8.3.1 Overview

    8.3.2 Subcutaneous: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

    8.4 Intravenous

    8.4.1 Overview

    8.4.2 Intravenous: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

    8.5 Intramuscular

    8.5.1 Overview

    8.5.2 Intramuscular: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

    9. Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 – Geographical Analysis

    9.1 North America: Sterile Compounding Pharmacies Market

    9.1.1 Overview

    9.1.2 North America: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.3 North America: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

    9.1.4 North America: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

    9.1.5 North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

    9.1.5.1 US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.5.1.1 Overview

    9.1.5.1.2 US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.5.1.3 US: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

    9.1.5.1.4 US: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

    9.1.5.2 Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.5.2.1 Overview

    9.1.5.2.2 Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.5.2.3 Canada: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

    9.1.5.2.4 Canada: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

    9.1.5.3 Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.5.3.1 Overview

    9.1.5.3.2 Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.1.5.3.3 Mexico: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)

    9.1.5.3.4 Mexico: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)

    9.2 Europe: Sterile Compounding Pharmacies Market

    9.2.1 Overview

    9.2.2 Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.3 Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.4 Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.2.5 Europe: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

    9.2.5.1 Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.1.1 Overview

    9.2.5.1.2 Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.1.3 Germany: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.1.4 Germany: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.2.5.2 France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.2.1 Overview

    9.2.5.2.2 France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.2.3 France: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.2.4 France: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.2.5.3 UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.3.1 Overview

    9.2.5.3.2 UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.3.3 UK: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.3.4 UK: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.2.5.4 Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.4.1 Overview

    9.2.5.4.2 Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.4.3 Italy: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.4.4 Italy: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.2.5.5 Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.5.1 Overview

    9.2.5.5.2 Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.5.3 Spain: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.5.4 Spain: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.2.5.6 Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.6.1 Overview

    9.2.5.6.2 Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.6.3 Rest of Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    9.2.5.6.4 Rest of Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    9.3 Asia Pacific Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028

    9.3.1 Overview

    9.3.2 Asia Pacific Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.3 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.4 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.3.5 Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

    9.3.5.1 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.1.1 Overview

    9.3.5.1.2 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.1.3 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.5.1.4 Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.3.5.2 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.2.1 Overview

    9.3.5.2.2 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.2.3 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.5.2.4 China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.3.5.3 India Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.3.1 Overview

    9.3.5.3.2 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.3.3 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.5.3.4 India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.3.5.4 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.4.1 Overview

    9.3.5.4.2 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.4.3 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.5.4.4 South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.3.5.5 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.5.1 Overview

    9.3.5.5.2 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.3.5.5.3 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.5.5.4 Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.3.5.6 Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.3.5.6.1 Overview

    9.3.5.6.2 Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    9.3.5.6.3 Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.3.5.6.4 Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.4 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028

    9.4.1 Overview

    9.4.2 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.3 Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.4.4 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.4.5 Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

    9.4.5.1 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.1.1 Overview

    9.4.5.1.2 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.1.3 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.4.5.1.4 UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

    9.4.5.2 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.2.1 Overview

    9.4.5.2.2 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.2.3 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.4.5.2.4 Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

    9.4.5.3 South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.3.1 Overview

    9.4.5.3.2 South Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.3.3 South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.4.5.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

    9.4.5.4 Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.4.1 Overview

    9.4.5.4.2 Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    9.4.5.4.3 Rest of Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    9.4.5.4.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

    9.5 South and Central America: Sterile Compounding Pharmacies Market-Revenue and Forecasts To 2028

    9.5.1 Overview

    9.5.2 South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

    9.5.3 South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    9.5.4 South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.5.5 South and Central America: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

    9.5.5.1 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    9.5.5.1.1 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    9.5.5.1.2 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    9.5.5.1.3 Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.5.5.2 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    9.5.5.2.1 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    9.5.5.2.2 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    9.5.5.2.3 Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    9.5.5.3 Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

    9.5.5.3.1 Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

    9.5.5.3.2 Rest of South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    9.5.5.3.3 Rest of South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    10. Impact Of COVID-19 Pandemic on Sterile Compounding Pharmacies Market

    10.1 North America: Impact Assessment of COVID-19 Pandemic

    10.2 Europe: Impact Assessment of COVID-19 Pandemic

    10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    10.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    11. Sterile Compounding Pharmacies Market–Industry Landscape

    11.1 Overview

    11.2 Growth Strategies in the Sterile Compounding Pharmacies Market (%)

    11.3 Organic Developments

    11.3.1 Overview

    11.4 Inorganic Developments

    11.4.1 Overview

    12. Company Profiles

    12.1 Fagron, Inc.

    12.1.1 Key Facts

    12.1.2 Business Description

    12.1.3 Products and Services

    12.1.4 Financial Overview

    12.1.5 SWOT Analysis

    12.1.6 Key Developments

    12.2 Triangle Compounding Pharmacy

    12.2.1 Key Facts

    12.2.2 Business Description

    12.2.3 Products and Services

    12.2.4 Financial Overview

    12.2.5 SWOT Analysis

    12.2.6 Key Developments

    12.3 B. Braun Melsungen AG

    12.3.1 Key Facts

    12.3.2 Business Description

    12.3.3 Products and Services

    12.3.4 Financial Overview

    12.3.5 SWOT Analysis

    12.3.6 Key Developments

    12.4 PharMEDium Healthcare Holdings, Inc.

    12.4.1 Key Facts

    12.4.2 Business Description

    12.4.3 Products and Services

    12.4.4 Financial Overview

    12.4.5 SWOT Analysis

    12.4.6 Key Developments

    12.5 Fresenius Kabi AG

    12.5.1 Key Facts

    12.5.2 Business Description

    12.5.3 Products and Services

    12.5.4 Financial Overview

    12.5.5 SWOT Analysis

    12.5.6 Key Developments

    12.6 Avella specialty pharmacy

    12.6.1 Key Facts

    12.6.2 Business Description

    12.6.3 Products and Services

    12.6.4 Financial Overview

    12.6.5 SWOT Analysis

    12.6.6 Key Developments

    12.7 Pencol Compounding Pharmacy

    12.7.1 Key Facts

    12.7.2 Business Description

    12.7.3 Products and Services

    12.7.4 Financial Overview

    12.7.5 SWOT Analysis

    12.7.6 Key Developments

    12.8 Pavilion Compounding Pharmacy, LLC.

    12.8.1 Key Facts

    12.8.2 Business Description

    12.8.3 Products and Services

    12.8.4 Financial Overview

    12.8.5 SWOT Analysis

    12.8.6 Key Developments

    12.9 Pace Pharmacy

    12.9.1 Key Facts

    12.9.2 Business Description

    12.9.3 Products and Services

    12.9.4 Financial Overview

    12.9.5 SWOT Analysis

    12.9.6 Key Developments

    12.10 SandsRx

    12.10.1 Key Facts

    12.10.2 Business Description

    12.10.3 Products and Services

    12.10.4 Financial Overview

    12.10.5 SWOT Analysis

    12.10.6 Key Developments

    13. Appendix

    13.1 About The Insight Partners

    13.2 Glossary of Terms


    LIST OF TABLES

    Table 1. North America Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 2. North America Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 3. US Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 4. US Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 5. Canada: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 6. Canada Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 7. Mexico: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 8. Mexico Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 9. Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 10. Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 11. Germany: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 12. Germany: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 13. France: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 14. France: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 15. UK: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 16. UK: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 17. Italy: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 18. Italy: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 19. Spain: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 20. Spain: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 21. Rest of Europe: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)

    Table 22. Rest of Europe: Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

    Table 23. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million).

    Table 24. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 25. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 26. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 27. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 28. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 29. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 30. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 31. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 32. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 33. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 34. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 35. Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 36. Rest of Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 37. Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 38. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 39. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 40. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 41. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 42. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 43. South Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 44. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 45. Rest of Middle East & Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 46. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 47. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 48. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 49. Brazil Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 50. Brazil Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 51. Argentina Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 52. Argentina Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 53. Rest of South and Central America Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Product (US$ Million)

    Table 54. Rest of South and Central America Sterile Compounding Pharmacies Market- Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

    Table 55. Organic Developments in the Sterile Compounding Pharmacies Market

    Table 56. Inorganic Developments in the Sterile Compounding Pharmacies Market

    Table 57. Glossary of Terms

    LIST OF FIGURES

    Figure 1. Sterile Compounding Pharmacies Market Segmentation

    Figure 2. Sterile Compounding Pharmacies Market, By Region

    Figure 3. Global Sterile Compounding Pharmacies Market Overview

    Figure 4. Injectable Drugs Segment Held Largest Share of Product Segment in Sterile Compounding Pharmacies Market

    Figure 5. North America is Expected to Show Remarkable Growth During the Forecast Period

    Figure 6. Sterile Compounding Pharmacies Market, by Geography (US$ Million)

    Figure 7. Global Sterile Compounding Pharmacies Market- Leading Country Markets (US$ Million)

    Figure 8. Global Sterile Compounding Pharmacies Market, Industry Landscape

    Figure 9. North America: PEST Analysis

    Figure 10. Europe: PEST Analysis

    Figure 11. Asia Pacific: PEST Analysis

    Figure 12. Middle East And Africa: PEST Analysis

    Figure 13. South And Central America: PEST Analysis

    Figure 14. Experts Opinion

    Figure 15. Impact Analysis of Drivers and Restraints About Sterile Compounding Pharmacies Market

    Figure 16. Global Sterile Compounding Pharmacies Market– Revenue Forecast and Analysis – 2021 - 2028

    Figure 17. Global Sterile Compounding Pharmacies Market – By Geography Forecast and Analysis – 2021 - 2028

    Figure 18. Market Positioning of Key Players in Global Sterile Compounding Pharmacies Market

    Figure 19. Global Sterile Compounding Pharmacies Market, by Product, 2021 & 2028 (%)

    Figure 20. Injectable Drugs: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 21. Infusions: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 22. Global Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)

    Figure 23. Subcutaneous: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 24. Intravenous: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 25. Intramuscular: Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 26. North America: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)

    Figure 27. North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

    Figure 28. North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

    Figure 29. US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 30. Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 31. Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 32. Europe: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)

    Figure 33. Europe: Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)

    Figure 34. Europe: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)

    Figure 35. Germany: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 36. France: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 37. UK: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 38. Italy: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 39. Spain: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 40. Rest of Europe: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 41. Asia Pacific Sterile Compounding Pharmacies Market Overview, by Country (2021)

    Figure 42. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 43. Asia Pacific: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

    Figure 44. Japan: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 45. China: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 46. India: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 47. South Korea: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 48. Australia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 49. Rest of Asia Pacific: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 50. Middle East & Africa Sterile Compounding Pharmacies Market Revenue Overview, by Country, 2021 (US$ Million)

    Figure 51. Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 52. Middle East & Africa Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

    Figure 53. UAE: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 54. Saudi Arabia: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 55. South Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 56. Rest of Middle East and Africa: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 57. South and Central America: Sterile Compounding Pharmacies Market, Revenue Overview, by Country, 2021 (US$ Million)

    Figure 58. South and Central America: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    Figure 59. South and Central America: Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028, By Country (%)

    Figure 60. Brazil: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    Figure 61. Argentina: Sterile Compounding Pharmacies Market- Revenue and Forecasts To 2028 (US$ Million)

    Figure 62. Rest of South and Central America: Sterile Compounding Pharmacies Market - Revenue and Forecast to 2028 (US$ Million)

    Figure 63. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 64. Impact of COVID-19 Pandemic in European Country Markets

    Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 66. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

    Figure 67. Impact of COVID-19 Pandemic on Sterile Compounding Pharmacies Market in South and Central American Countries

    Figure 68. Growth Strategies in the Sterile Compounding Pharmacies Market (%)

    The List of Companies - sterile compounding pharmacies market

    1. Fagron, Inc.
    2. Triangle Compounding Pharmacy
    3. B. Braun Melsungen AG
    4. PharMedium Healthcare Holdings, Inc.
    5. Fresenious Kabi AG
    6. Avella Specialty Pharmacy
    7. Pencol Compounding Pharmacy
    8. Pavilion Compounding Pharmacy, LLC.
    9. Pace Pharmacy
    10. SandsRx                                    
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the sterile compounding pharmacies market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global sterile compounding pharmacies market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
    TIPRE00026302
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount